Recuvyra

RSS

Expired

This medicine's authorisation has expired

fentanyl
MedicineVeterinaryExpired

Icelandic is available via eTranslation, the European Commission's machine translation service.

Translate to Icelandic | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Recuvyra has expired following the marketing-authorisation holder’s decision not to apply for a renewal.

български (BG) (568.84 KB - PDF)

Skoða

español (ES) (537.02 KB - PDF)

Skoða

čeština (CS) (573.8 KB - PDF)

Skoða

dansk (DA) (511.6 KB - PDF)

Skoða

Deutsch (DE) (515.35 KB - PDF)

Skoða

eesti (ET) (539.37 KB - PDF)

Skoða

ελληνικά (EL) (586.2 KB - PDF)

Skoða

français (FR) (538.28 KB - PDF)

Skoða

italiano (IT) (535.2 KB - PDF)

Skoða

latviešu (LV) (569.81 KB - PDF)

Skoða

lietuvių (LT) (534.12 KB - PDF)

Skoða

magyar (HU) (548.34 KB - PDF)

Skoða

Malti (MT) (576.33 KB - PDF)

Skoða

Nederlands (NL) (513.44 KB - PDF)

Skoða

polski (PL) (552.75 KB - PDF)

Skoða

português (PT) (535.52 KB - PDF)

Skoða

română (RO) (533.59 KB - PDF)

Skoða

slovenčina (SK) (570.05 KB - PDF)

Skoða

slovenščina (SL) (564.24 KB - PDF)

Skoða

suomi (FI) (533.75 KB - PDF)

Skoða

svenska (SV) (535.74 KB - PDF)

Skoða

Product information

български (BG) (1.46 MB - PDF)

Skoða

español (ES) (876.92 KB - PDF)

Skoða

čeština (CS) (1.18 MB - PDF)

Skoða

dansk (DA) (873.6 KB - PDF)

Skoða

Deutsch (DE) (889.37 KB - PDF)

Skoða

eesti (ET) (830.81 KB - PDF)

Skoða

ελληνικά (EL) (1.51 MB - PDF)

Skoða

français (FR) (864.23 KB - PDF)

Skoða

hrvatski (HR) (875.28 KB - PDF)

Skoða

italiano (IT) (859.62 KB - PDF)

Skoða

latviešu (LV) (1.25 MB - PDF)

Skoða

lietuvių (LT) (810.52 KB - PDF)

Skoða

magyar (HU) (1.25 MB - PDF)

Skoða

Malti (MT) (1.26 MB - PDF)

Skoða

Nederlands (NL) (855.45 KB - PDF)

Skoða

polski (PL) (1.23 MB - PDF)

Skoða

português (PT) (838.3 KB - PDF)

Skoða

română (RO) (1 MB - PDF)

Skoða

slovenčina (SK) (1.18 MB - PDF)

Skoða

slovenščina (SL) (1.13 MB - PDF)

Skoða

suomi (FI) (858.03 KB - PDF)

Skoða

svenska (SV) (851.7 KB - PDF)

Skoða

Íslenska (IS) (879.42 KB - PDF)

Skoða

norsk (NO) (836.37 KB - PDF)

Skoða
Latest procedure affecting product information:IB/0009/G
13/10/2016

български (BG) (498.29 KB - PDF)

Skoða

español (ES) (458.29 KB - PDF)

Skoða

čeština (CS) (487.32 KB - PDF)

Skoða

dansk (DA) (460.34 KB - PDF)

Skoða

Deutsch (DE) (460.75 KB - PDF)

Skoða

eesti (ET) (460.29 KB - PDF)

Skoða

ελληνικά (EL) (495.78 KB - PDF)

Skoða

français (FR) (460.31 KB - PDF)

Skoða

hrvatski (HR) (471.53 KB - PDF)

Skoða

italiano (IT) (460.57 KB - PDF)

Skoða

latviešu (LV) (491.15 KB - PDF)

Skoða

lietuvių (LT) (475.45 KB - PDF)

Skoða

magyar (HU) (485.61 KB - PDF)

Skoða

Malti (MT) (488.27 KB - PDF)

Skoða

Nederlands (NL) (458.26 KB - PDF)

Skoða

polski (PL) (485.72 KB - PDF)

Skoða

português (PT) (460.24 KB - PDF)

Skoða

română (RO) (474.03 KB - PDF)

Skoða

slovenčina (SK) (487.71 KB - PDF)

Skoða

slovenščina (SL) (477.71 KB - PDF)

Skoða

suomi (FI) (458.28 KB - PDF)

Skoða

svenska (SV) (460.23 KB - PDF)

Skoða

Íslenska (IS) (457.47 KB - PDF)

Skoða

norsk (NO) (461.18 KB - PDF)

Skoða

Product details

Name of medicine
Recuvyra
Active substance
fentanyl
International non-proprietary name (INN) or common name
fentanyl
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QN02AB03

Pharmacotherapeutic group

Nervous system

Therapeutic indication

For the control of pain associated with orthopaedic and soft tissue surgery in dogs.

Authorisation details

EMA product number
EMEA/V/C/002239
Marketing authorisation holder
Eli Lilly and Company Limited 

Eli Lilly and Company Limited
Lilly House
Priestley Road
Basingstoke
Hampshire RG24 9NL
United Kingdom

Marketing authorisation issued
06/10/2011
Expiry of marketing authorisation
13/10/2016
Revision
4

Assessment history

This page was last updated on

Share this page